ArticleGynecologic oncology2020

CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes.

Shariska Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.